当前位置: 首页 > 期刊 > 《中国医学创新》 > 20201
编号:13518033
肾小球滤过率对急性冠脉综合征并行PCI患者预后的影响(5)
http://www.100md.com 2020年1月5日 《中国医学创新》 20201
     [16] Sarnak M J,Levey A S,Schoolwerth A C,et al.Kidney disease as a risk factor for development of cardiovascular disease:a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention[J].Hypertension,2003,42(5):1050-1065.

    [17] Sakamoto N,Iwaya S,Owada T,et al.A reduction of coronary flow reserve is associated with chronic kidney disease and long-term cardio-cerebrovascular events in patients with non-obstructive coronary artery disease and vasospasm[J].Fukushima J Med Sci,2012,58(2):136-143.

    [18] Baigent C,Landray M J,Reith C,et al.The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease(Study of Heart and Renal Protection):a randomized placebo-controlled trial[J].Lancet,2011,377(9784):2181-2192.

    [19] Stehouwer C D,Smulders Y M.Microalbuminuria and risk for cardiovascular disease:analysis of potential mechanisms[J].J Am Soc Nephrol,2006,17(8):2106-2111.

    [20] Shlipak M G,Fried L F,Crump C,et al.Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency[J].Circulation,2003,107(1):87-92.

    (收稿日期:2019-05-27)(本文編辑:田婧), http://www.100md.com(倪智航 段玮丽 武佳科 温宗玉 何东旭 焦云娣 孙志军 孙兆青)
上一页1 2 3 4 5